Tech Company Financing Transactions
Sensydia Funding Round
Sensydia, based in Los Angeles, secured $3 million in funding from National Institutes of Health.
Transaction Overview
Company Name
Announced On
6/2/2023
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
National Institutes of Health (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the development and clinical testing of the machine learning algorithms for the Cardiac Performance System (CPS), designed to enable earlier detection and therapy guidance for patients with heart failure and pulmonary hypertension.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1100 Glendon Ave. 1724
Los Angeles, CA 90024
USA
Los Angeles, CA 90024
USA
Phone
Undisclosed
Website
Email Address
Overview
Sensydia Corp operates in healthcare industry. The company was incorporated in 2015 and is headquartered in Los Angeles, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Bruggere
Chief Marketing Officer
Aman Mahajan
Chief Technical Officer
Wiliam Kaiser
Browse more venture capital transactions:
Prev: 6/2/2023: Red 6 venture capital transaction
Next: 6/2/2023: Jeff venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs